Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug 10;18(8):1739.
doi: 10.3390/ijms18081739.

Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

Ewgeni Jakubovski  1 , Kirsten Müller-Vahl  2
Affiliations
Case Reports

Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

Ewgeni Jakubovski et al. Int J Mol Sci. .

Abstract

We report the cases of two young German male patients with treatment-resistant Tourette syndrome (TS), who suffer from incapacitating stuttering-like speech disfluencies caused by vocal blocking tics and palilalia. Case 1: a 19-year old patient received medical cannabis at a dose of 1 × 0.1 g cannabis daily. Case 2: a 16-year old patient initially received dronabinol at a maximum dose of 22.4-33.6 mg daily. Both treatments provided significant symptom improvement of vocal blocking tics as well as of comorbid conditions and were well tolerated. Thus, cannabis-based medicine appears to be effective in treatment-resistant TS patients with vocal blocking tics.

Keywords: Tourette syndrome; blocking tics; cannabis; dysfluency; nabiximols; tics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J. Psychosom. Res. 2009;67:475–483. doi: 10.1016/j.jpsychores.2009.07.010. - DOI - PubMed
    1. Knight T., Steeves T., Day L., Lowerison M., Jette N., Pringsheim T. Prevalence of tic disorders: A systematic review and meta-analysis. Pediatr. Neurol. 2012;47:77–90. doi: 10.1016/j.pediatrneurol.2012.05.002. - DOI - PubMed
    1. Sambrani T., Jakubovski E., Müller-Vahl K.R. New insights into clinical characteristics of Gilles de la Tourette syndrome: Findings in 1032 patients from a single German center. Front. Neurosci. 2016 doi: 10.3389/fnins.2016.00415. - DOI - PMC - PubMed
    1. Ganos C., Müller-Vahl K., Bhatia K.P. Blocking phenomena in Gilles de la Tourette syndrome. Mov. Disord. Clin. Pract. 2015;2:438–439. doi: 10.1002/mdc3.12199. - DOI - PMC - PubMed
    1. Abwender D.A., Trinidad K.S., Jones K.R., Como P.G., Hymes E., Kurlan R. Features resembling Tourette’s syndrome in developmental stutterers. Brain Lang. 1998;62:455–464. doi: 10.1006/brln.1998.1948. - DOI - PubMed

Publication types